Report of the 95th European Neuromuscular Centre (ENMC) sponsored International Workshop Cognitive Impairment in Neuromuscular Disorders, Naarden, The Netherlands, 13-15 July 2001

Neuromuscular Disorders

Volumn 13, Issue 1, 2003, Pages 72-79

  D'Angelo, M G ^a   Bresolin, N ^a,b  

^a SCIENTIFIC INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cognitive impairment; Neuromuscular disorders

Indexed keywords

BECKER MUSCULAR DYSTROPHY; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DUCHENNE MUSCULAR DYSTROPHY; ENCEPHALOMYOPATHY; LIMB GIRDLE MUSCULAR DYSTROPHY; MEDICAL RESEARCH; MITOCHONDRIAL MYOPATHY; MOLECULAR INTERACTION; MUTATION; MYOTONIC DYSTROPHY; NETHERLANDS; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASES;

EID: 0037211805     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00155-4     Document Type: Conference Paper

References (35)

1. Karagan N.J. Intellectual functioning in Duchenne muscular dystrophy: a review. Psychol Bull. 86:1978;250-259.
2. Leibowitz D., Dubowitz V. Intellect and behavior in Duchenne muscular dystrophy. Dev Med Child Neurol. 23:1981;577-590.
3. Emery A.E.H. Duchenne muscular dystrophy. 2nd. 1993;115-120.
4. Comi G.P., Bresolin N., Bardoni A. Absence of mental retardation in a large DMD gene deletion involving brain dystrophin promoter. Neurology. 43:(Suppl. 1):1993;313. Letter.
5. Blake D.J., Love D.R., Tinsley J., et al. Characterization of a 4.8 kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Hum Mol Genet. 1:1992;103-109.
6. Lidov H.G., Selig S., Kunkel L.M. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 4:(3):1995 Mar;329-333.
7. Bardoni A., Sironi M., Felisari G., Comi G.P., Bresolin N. Absence of brain Dp140 isoform and cognitive impairment in Becker muscular dystrophy. Lancet. 353:(9156):1999;897-898.
8. Felisari G., Martinelli Boneschi F., Bardoni A., et al. Loss of Dp140 dystrophin and intellectual impairment in Duchenne dystropphy. Neurology. 55:2000;559-564.
9. Moizard M.P., Billard C., Toutain A., Berret F., Marmin N., Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 80:(1):1998;32-41.
10. Moizard M.P., Toutain A., Fournier D., et al. Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet. 8:(7):2000;552-556.
11. Fabbro F. Neurolinguistica e Neuropsicologia dei disturbi specifici del linguaggio nel bambino. Saggi di Neuropsicologia infantile, Psicopedagogia, Riabilitazione. 24:1999;11-23.
12. Bushby K.M., Apleton R., Anderson L.V., Welch J.L., Kelly P., Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol. 37:(3):1995;260-269.
13. Vaillend C., Rendon A., Misslin R., Ungerer A. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks. Behav Genet. 25:1995;569-579.
14. 3cv mice lacking dystrophin-brain isoforms. Neuroscience. 86:1998;53-66.
15. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
16. Vaillend C., Ungerer A., Billard J.-M. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice. Synapse. 33:1999;59-70.
17. A receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci. 11:1999;4457-4462.
18. Brenman J.E., Bredt D.S. Synaptic signaling by nitric oxide. Curr Opin Neurobiol. 7:1997;374-378.
19. 3cv mice deficient in C-terminal dystrophins. Neuromuscul Disord. 9:1999;296-304.
20. 3cv mice lacking dystrophin-brain isoforms. Neuroscience. 86:1998;53-66.
21. Blake D.J., Hawkes D.J., Benson M.A., Beesley P.W. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol. 147:(3):1999;645-658.
22. Culligan K., Glover L., Dowling P., Ohlendiek K. Brain dystrophin-glycoprotein complex: persistent expression of β-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. BMC Cell Biol. 2:2001;1471-2121.
23. Newey S.E., Benson M.A., Ponting C.P., Davies K.E., Blake D.J. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex. Curr Biol. 10:(20):2000;1295-1298.
24. Blake D.J., Hawkes R., Benson M.A., Beeslly P.W. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol. 147:(3):1999;645-658.
25. Aleman V., Osorio B., Chavez O., Rendon A., Moenet D., Martinez D. Subcellular localization of Dp71 dystrophin isoforms in cultured hippocampal neurons and forebrain astrocytes. Histochem Cell Biol. 115:(3):2001;243-254.
26. Sarig R., Mezger-Lallemand V., Gitelman I., et al. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development. Hum Mol Genet. 8:(1):1999;1-10.
27. Harper P.S. Myotonic dystrophy. 2nd ed. 1989;Saunders, Philadelphia, USA.
28. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of trinucleotide (CGT) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 68:1992;799-808.
29. Whiting E.J., Waring J.D., Tamai K., et al. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. Hum Mol Genet. 4:(6):1995;1063-1072.
30. Balasubramanyam A., Iyer D., Stringer J.L., et al. Developmental changes in expression of myotonic dystrophy protein kinase in the rat central nervous system. J Comp Neurol. 394:(3):1998;309-325.
31. Otten A.D., Tapscott S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci USA. 92:(12):1995;5465-5469.
32. Annane D., Fiorelli M., Mazoyer B., et al. Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon. Neuromuscul Disord. 8:(1):1998;39-45.
33. Censori B., Provinciali L., Danni M., et al. Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions. Acta Neurol Scand. ? (3):1994;211-217.
34. Cagliani R., Comi G.P., Tancredi L., et al. Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria. Neuromuscul Disord. 11:(4):2001;389-394.
35. Turconi A.C., Benti R., Castelli E., et al. Focal cognitive impairment in mitochondrial encephalomyopathies: neuropsycological and neuroimaging study. J Neurol Sci. 170:1999;57-63.